Factors influencing the protective efficacy of a BCG homologous prime-boost vaccination regime against tuberculosis
- 6 February 2006
- Vol. 24 (6), 835-845
- https://doi.org/10.1016/j.vaccine.2005.07.033
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Nasal boost with adjuvanted heat-killed BCG or arabinomannan–protein conjugate improves primary BCG-induced protection in C57BL/6 miceTuberculosis, 2005
- Vaccination of neonatal calves withMycobacterium bovisBCG induces protection against intranasal challenge with virulentM. bovisClinical and Experimental Immunology, 2004
- A DNA Prime- Mycobacterium bovis BCG Boost Vaccination Strategy for Cattle Induces Protection against Bovine TuberculosisInfection and Immunity, 2003
- A review of tuberculosis: reflections on the past, present and future of a global epidemic diseaseExpert Review of Anti-infective Therapy, 2003
- Oral Delivery ofMycobacterium bovisBCG in a Lipid Formulation Induces Resistance to Pulmonary Tuberculosis in MiceInfection and Immunity, 2003
- Tuberculosis in free-ranging wildlife: detection, diagnosis and managementRevue Scientifique et Technique de l'OIE, 2002
- Intranasal BCG vaccination protects BALB/c mice against virulentMycobacterium bovisand accelerates production of IFN-γ in their lungsClinical and Experimental Immunology, 2001
- Tuberculosis vaccine development: recent progressTrends in Microbiology, 2001
- Enhanced Immunogenicity of CD4+T-Cell Responses and Protective Efficacy of a DNA-Modified Vaccinia Virus Ankara Prime-Boost Vaccination Regimen for Murine TuberculosisInfection and Immunity, 2001
- Differential Protective Efficacy of DNA Vaccines Expressing Secreted Proteins ofMycobacterium tuberculosisInfection and Immunity, 1999